58 results
Page 2 of 3
8-K
EX-10.1
lu8uub9yzugai0u0yk
2 Mar 21
Departure of Directors or Certain Officers
4:01pm
DEFA14A
33l2kp1k8ne zgrc7
4 Dec 20
Additional proxy soliciting materials
5:25pm
DEFA14A
itf w4227x4n0vcvke
30 Nov 20
Additional proxy soliciting materials
5:30pm
DEFA14A
vsmh3elt
20 Nov 20
Additional proxy soliciting materials
12:00am
8-K
EX-99.2
cq11x2d
5 Nov 20
Ziopharm Oncology Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
m0rl co7ml
29 May 20
Ziopharm Oncology Presents Encouraging Clinical Data for ControlledIL-12 for the Treatment of Recurrent Glioblastoma
8:16am
8-K
EX-99.1
wpp2hs
7 May 20
Ziopharm Oncology Reports First Quarter 2020 Financial Results
4:10pm